跳至主要内容
临床试验/NCT01383694
NCT01383694已完成1 期

Effect of Natural Agonists of TRPV1 in the Treatment of Functional Oropharyngeal Dysphagia in Neurological Diseases and the Elderly: Piperine

Hospital de Mataró1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Safety of swallow

研究概览

简要总结

Piperine acts on the oropharyngeal TRPV1, increasing sensory input and the release of substance P. These actions may accelerate the oropharyngeal swallow response, improving the swallowing of dysphagic patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of swallowing difficulties associated with aging and/or neurological diseases (neurodegenerative or non-progressive neurological diseases)
  • Study explained and written subject information given
  • Informed consent signed

排除标准

  • Patients suffering idiosyncratic phenomena or who are allergic to any medication, especially iodinated contrast media
  • Patients suffering major respiratory disease or undergoing any type of surgery in the three months prior to the study
  • Patients with a background of alcohol dependence or other drug dependence
  • Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of the study

研究组 & 干预措施

Piperine Dose 1

Experimental

Piperine 1 mM

干预措施: Piperine (Drug)

Piperine Dose 2

Experimental

Piperine 150 microM

干预措施: Piperine (Drug)

结局指标

主要结局

Safety of swallow

时间窗: 15 minutes

Prevalence of penetrations at the laryngeal vestibule

次要结局

  • Efficacy of swallow(15 minutes)

研究者

发起方
Hospital de Mataró
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pere Clave

MD, PhD

Hospital de Mataró

研究点 (1)

Loading locations...

相似试验

Effect Of Piperine In Patients With Oropharyngeal... | 临床试验